Skip to main content
Top
Published in: World Journal of Surgery 6/2005

01-06-2005

Preoperative Albendazole and Scolices Viability in Patients with Hepatic Echinococcosis

Authors: Carlos Manterola, M.D., Ph.D., Juan A. Mansilla, M.D., Flery Fonseca, M.Sc.

Published in: World Journal of Surgery | Issue 6/2005

Login to get access

Abstract

To determine the plasmatic and intracystal concentrations of albendazole sulfoxide (AS) and correlate them with the viability of the scolices in patients surgically treated for hepatic hydatid cysts (HHC) that received albendazole preoperatively, as an indirect way of evaluating the scolicide efficacy of the drug. A non-consecutive series of patients with uncomplicated HHC, underwent operation at the Department of Surgery, Regional Hospital of Temuco, Chile, between 2001 and 2002. The patients were given 10 mg/kg/day of albendazole for 4 days prior to the surgery. Intraoperative samples of venous blood and hydatid fluid were taken, in which the plasmatic concentration (PIC) and intracystal concentration (ICC) of AS were measured by means of high-performance liquid chromatography. With the remaining hydatid fluid, the viability of the scolices was examined. The following variables were taken into consideration: diameter, type of cyst, number of cysts, and development of cyst–biliary communications. Descriptive statistics were used in the calculation of medians, averages, and standard deviations, and analytical statistics were used for the comparison of continuous variables applying the t-test and the Mann-Whitney U-test. A total of 26 patients with HHC, with a median age of 39.5 years (range: 16–80 years); 16 were women (61.5%). Nineteen patients presented only one cyst (73.1%), and the diametric median of the cysts was 14.5 cm (range: 7–30). Fourteen patients presented univesicular cysts (53.9%), and the remaining 12 had multivesicular cysts (46.1%). The average PIC of AS in the whole series was 1.88 ± 0.5 μg/ml and the ICC was 0.26 ± 0.2 μg/ml. The ICC in viable hydatid cysts was 0.25 μg/ml versus 0.28 μg/ml in non-viable cysts (p = 0.7556). The absence of association between intracystal levels of AS and the viability of the scolices allows one to posit indirectly that albendazole is ineffective as a scolicidal agent administered preoperatively for 4 days.
Literature
1.
go back to reference Sapunar J. Hidatidosis. In Atíias A. Neghme A, editors, Parasitología Clíníca, Mediterráneo, 1984;297–311 Sapunar J. Hidatidosis. In Atíias A. Neghme A, editors, Parasitología Clíníca, Mediterráneo, 1984;297–311
2.
go back to reference Apt, W, Pérez, C, Rycke, P. 1996Nonconventional treatment of human hydatidosisRev. Med. Chile12413851389PubMed Apt, W, Pérez, C, Rycke, P. 1996Nonconventional treatment of human hydatidosisRev. Med. Chile12413851389PubMed
3.
go back to reference Manterola, C, Acencio, L, Bahamondes, J, et al. 1997Liver hydatidosis. Descriptive study of clinical and therapeutic aspects of a consecutive series of casesRev. Chil. Cir. (Chile)49352359 Manterola, C, Acencio, L, Bahamondes, J,  et al. 1997Liver hydatidosis. Descriptive study of clinical and therapeutic aspects of a consecutive series of casesRev. Chil. Cir. (Chile)49352359
5.
go back to reference Busel, D. 1991Hydatidosis epidemiology. determination of high risk groups and the utility of educational interventions as rational alternativeRev. Med. Surg. (Chile)161011 Busel, D. 1991Hydatidosis epidemiology. determination of high risk groups and the utility of educational interventions as rational alternativeRev. Med. Surg. (Chile)161011
6.
go back to reference Franchi, C, Di Vico, B, Teggi, A. 1999Long-term evaluation of patients with hydatidosis treated with benzimidazole carbamatesClin. Infect. Dis.29304309CrossRefPubMed Franchi, C, Di Vico, B, Teggi, A. 1999Long-term evaluation of patients with hydatidosis treated with benzimidazole carbamatesClin. Infect. Dis.29304309CrossRefPubMed
7.
go back to reference Serra, I, García, V, Pizarro, A, et al. 1999A universal method to correct underreporting of communicable diseasesReal incidence of hydatidosis in Chile 1985–1994. Rev. Med. Chile127485492 Serra, I, García, V, Pizarro, A,  et al. 1999A universal method to correct underreporting of communicable diseasesReal incidence of hydatidosis in Chile 1985–1994. Rev. Med. Chile127485492
8.
go back to reference Morris, DL, Chinnery, JB, Georgiou, G, et al. 1987Penetration of albendazole sulphoxide into hydatid cystsGut287580PubMed Morris, DL, Chinnery, JB, Georgiou, G,  et al. 1987Penetration of albendazole sulphoxide into hydatid cystsGut287580PubMed
9.
go back to reference Manterola, C, Barroso, M, Vial, M, et al. 2003Liver abscess of hydatid origin: clinical features and results of aggressive treatmentAust. N. Z. J. Surg.73220224CrossRef Manterola, C, Barroso, M, Vial, M,  et al. 2003Liver abscess of hydatid origin: clinical features and results of aggressive treatmentAust. N. Z. J. Surg.73220224CrossRef
10.
go back to reference Barriga, O. 1971Survival of Echinococcus granulosus scolices in saline solution and in hydatid fluid at different temperaturesBol. Chil. Parasitol.268084PubMed Barriga, O. 1971Survival of Echinococcus granulosus scolices in saline solution and in hydatid fluid at different temperaturesBol. Chil. Parasitol.268084PubMed
11.
go back to reference García Llamazares, JL, Alvarez Felipe, AL, Redondo, PA, et al. 1997Fertility and viability study of ovine hydatid cystsRev. Esp. Salud Publica71445449PubMed García Llamazares, JL, Alvarez Felipe, AL, Redondo, PA,  et al. 1997Fertility and viability study of ovine hydatid cystsRev. Esp. Salud Publica71445449PubMed
12.
go back to reference Manterola, C, Oberg, C, Soto, O, et al. 2000Scolex viability of human liver hydatid cystsRev. Chil. Cir. (Chile)52471476 Manterola, C, Oberg, C, Soto, O,  et al. 2000Scolex viability of human liver hydatid cystsRev. Chil. Cir. (Chile)52471476
13.
go back to reference Laboratorio Merck. Introduction to HPLC. Practical Applications. Santiago, Chile, Merck, 1990;3–50 Laboratorio Merck. Introduction to HPLC. Practical Applications. Santiago, Chile, Merck, 1990;3–50
14.
go back to reference Zeugin, T, Zysset, T, Cotting, J. 1990Therapeutic monitoring of albendazole: a high-performance Liquid chromatography method for determination of its active metabolite albendazole sulfoxideTher. Drug Monit.12187190PubMed Zeugin, T, Zysset, T, Cotting, J. 1990Therapeutic monitoring of albendazole: a high-performance Liquid chromatography method for determination of its active metabolite albendazole sulfoxideTher. Drug Monit.12187190PubMed
15.
go back to reference Valois, ME, Takayanagui, OM, Bonato, PS, et al. 1994Determination of albendazole metabolites in plasma by HPLCJ. Anal. Toxicol.188690PubMed Valois, ME, Takayanagui, OM, Bonato, PS,  et al. 1994Determination of albendazole metabolites in plasma by HPLCJ. Anal. Toxicol.188690PubMed
16.
go back to reference Morris, D, Dykes, P, Marriner, S, et al. 1985Albendazole: objective evidence of response in human hydatid diseaseJ.A.M.A.25320532057PubMed Morris, D, Dykes, P, Marriner, S,  et al. 1985Albendazole: objective evidence of response in human hydatid diseaseJ.A.M.A.25320532057PubMed
17.
go back to reference García, J, Bolás-Fernández, F, Torrado, J. 1999Quantitative determination of albendazole and its main metabolites in plasmaJ. Chromatogr. B Biomed. Sci. Appl.723265271CrossRefPubMed García, J, Bolás-Fernández, F, Torrado, J. 1999Quantitative determination of albendazole and its main metabolites in plasmaJ. Chromatogr. B Biomed. Sci. Appl.723265271CrossRefPubMed
18.
go back to reference Morris, DL. 1987Preoperative albendazole therapy for hydatid cystBr. J. Surg.74805806PubMed Morris, DL. 1987Preoperative albendazole therapy for hydatid cystBr. J. Surg.74805806PubMed
19.
go back to reference Gil-Grande, LA, Rodríguez-Caabeiro, F, Prieto, JG, et al. 1993Randomized controlled trial of efficacy of albendazole in intra-abdominal hydatid diseaseLancet34212691272CrossRefPubMed Gil-Grande, LA, Rodríguez-Caabeiro, F, Prieto, JG,  et al. 1993Randomized controlled trial of efficacy of albendazole in intra-abdominal hydatid diseaseLancet34212691272CrossRefPubMed
20.
go back to reference Aktan, AO, Yalin, R. 1996Preoperative albendazole treatment for liver hydatid disease decreases the viability of the cystEur. J. Gastroenterol. Hepatol.8877879PubMed Aktan, AO, Yalin, R. 1996Preoperative albendazole treatment for liver hydatid disease decreases the viability of the cystEur. J. Gastroenterol. Hepatol.8877879PubMed
Metadata
Title
Preoperative Albendazole and Scolices Viability in Patients with Hepatic Echinococcosis
Authors
Carlos Manterola, M.D., Ph.D.
Juan A. Mansilla, M.D.
Flery Fonseca, M.Sc.
Publication date
01-06-2005
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 6/2005
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-005-7691-6

Other articles of this Issue 6/2005

World Journal of Surgery 6/2005 Go to the issue

OriginalPaper

To the Editor